Efficacy of Tacrolimus in Uveitis, and the Usefulness of Serum Tacrolimus Levels in Predicting Disease Control. Results from a Single Large Center

References

• Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130(4):492–513.
   PubMed Web of Science ®Google Scholar
• Duncan MD, Wilkes DS. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections. Proc Am Thorac Soc. 2005;2(5):449–455. doi:10.1513/pats.200507-073JS. [published Online First: Epub Date]|.
   PubMedGoogle Scholar
• Jabs DA. Immunosuppression for the Uveitides. Ophthalmology. 2018;125(2):193–202. doi:10.1016/j.ophtha.2017.08.007. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Rathinam SR, Gonzales JA, Thundikandy R, et al. Effect of corticosteroid-sparing treatment with mycophenolate mofetil vs methotrexate on inflammation in patients with uveitis: a randomized clinical trial. JAMA. 2019;322(10):936–945. doi:10.1001/jama.2019.12618. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Hogan AC, McAvoy CE, Dick AD, Lee RW. Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis. Ophthalmology. 2007;114(5):1000–1006. doi:10.1016/j.ophtha.2007.01.026. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Lee RW, Greenwood R, Taylor H, et al. A randomized trial of tacrolimus versus tacrolimus and prednisone for the maintenance of disease remission in noninfectious uveitis. Ophthalmology. 2012;119(6):1223–1230. doi:10.1016/j.ophtha.2011.12.030. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Islam F, Westcott M, Rees A, et al. Safety profile and efficacy of tacrolimus in the treatment of birdshot retinochoroiditis: a retrospective case series review. Br J Ophthalmol. 2018;102(7):983–990. doi:10.1136/bjophthalmol-2017-310436. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Knickelbein JE, Kim M, Argon E, Nussenblatt RB, Sen NH. Comparative efficacy of steroid-sparing therapies for non-infectious uveitis. Expert Rev Ophthalmol. 2017;12(4):313–319. doi:10.1080/17469899.2017.1319762. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Onodera M, Endo K, Naito T, et al. Tacrolimus dose optimization strategy for refractory ulcerative colitis based on the cytochrome P450 3A5 polymorphism prediction using trough concentration after 24 hours. Digestion. 2018;97(1):90–96. doi:10.1159/000484227. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2004;43(10):623–653. doi:10.2165/00003088-200443100-00001. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Wallemacq P, Armstrong VW, Brunet M, et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit. 2009;31(2):139–152. doi:10.1097/FTD.0b013e318198d092. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Murphy CC, Greiner K, Plskova J, et al. Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis. Arch Ophthalmol. 2005;123(5):634–641. doi:10.1001/archopht.123.5.634. [published Online First: Epub Date]|.
   PubMedGoogle Scholar
• Pasadhika S, Kempen JH, Newcomb CW, et al. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009;148(4):500–09 e2. doi:10.1016/j.ajo.2009.05.008. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Gangaputra S, Newcomb CW, Liesegang TL, et al. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009;116(11):2188–98 e1. doi:10.1016/j.ophtha.2009.04.020. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Daniel E, Thorne JE, Newcomb CW, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010;149(3):423–32 e1-2. doi:10.1016/j.ajo.2009.09.026. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Pujari SS, Kempen JH, Newcomb CW, et al. Cyclophosphamide for ocular inflammatory diseases. Ophthalmology. 2010;117(2):356–365. doi:10.1016/j.ophtha.2009.06.060. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Kacmaz RO, Kempen JH, Newcomb C, et al. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010;117(3):576–584. doi:10.1016/j.ophtha.2009.08.010. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121(3):785–96 e3. doi:10.1016/j.ophtha.2013.09.048. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Sheppard J, Joshi A, Betts KA, et al. Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials. JAMA Ophthalmol. 2017;135(6):511–518. doi:10.1001/jamaophthalmol.2017.0603. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Jaffe GJ, Dick AD, Brezin AP, et al. Adalimumab in patients with active noninfectious uveitis. N Engl J Med. 2016;375(10):932–943. doi:10.1056/NEJMoa1509852. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Nguyen QD, Merrill PT, Jaffe GJ, et al. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016;388(10050):1183–1192. doi:10.1016/S0140-6736(16)31339-3. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Ming S, Xie K, He H, Li Y, Lei B. Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review. Drug Des Devel Ther. 2018;12:2005–2016. doi:10.2147/DDDT.S160431. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Cordero-Coma M, Yilmaz T, Onal S. Systematic review of anti-tumor necrosis factor-alpha therapy for treatment of immune-mediated uveitis. Ocul Immunol Inflamm. 2013;21(1):19–27. doi:10.3109/09273948.2012.723107. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Gangaputra SS, Newcomb CW, Joffe MM, et al. Comparison between methotrexate and mycophenolate mofetil monotherapy for the control of noninfectious ocular inflammatory diseases. Am J Ophthalmol. 2019;208:68–75. doi:10.1016/j.ajo.2019.07.008. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Macchi-Andanson M, Charpiat B, Jelliffe RW, Ducerf C, Fourcade N, Baulieux J. Failure of traditional trough levels to predict tacrolimus concentrations. Ther Drug Monit. 2001;23(2):129–133. doi:10.1097/00007691-200104000-00006. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Asberg A, Midtvedt K, Van Guilder M, et al. Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation. Transpl Int. 2013;26(12):1198–1207. doi:10.1111/tri.12194. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Scheel J, Reber S, Stoessel L, et al. Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation. BMC Nephrol. 2017;18(1):107. doi:10.1186/s12882-017-0517-6. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar
• Uchiyama E, Papaliodis GN, Lobo AM, Sobrin L. Side-effects of anti-inflammatory therapy in uveitis. Semin Ophthalmol. 2014;29(5–6):456–467. doi:10.3109/08820538.2014.959203. [published Online First: Epub Date]|.
   PubMed Web of Science ®Google Scholar